We're passionately focused on the continued innovation and science behind our AtriClip® device portfolio. With over 600,000 devices implanted and more than 90 studies, we’re setting the gold standard to surgical LAAE.​

Stop by booth 915 at <a href="https://twitter.com/hashtag/HRS2025?src=hashtag_click&quot; target="_blank">#HRS2025</a> to see the latest

At AtriCure, we’re passionately focused on the continued innovation and science behind our AtriClip® device portfolio. With over 600,000 devices implanted and more than 90 studies, we’re setting the gold standard to surgical LAAE.​

Stop by booth 915 at <a href='https://www.linkedin.com/feed/hashtag/?keywords=HRS2025&highlightedUpda…; target='_blank'>#HRS2025</a> to see the latest AtriClip device innovation.

Designed to reduce the risks associated with standard epicardial access techniques, the EPi-Ease™ Device is providing electrophysiologists another option for accessing the pericardium.​
Discover how by visiting us at <a href="https://twitter.com/hashtag/HRS2025?src=hashtag_click&quot; target="_blank">#HRS2025</a> at booth 915. ​

Important Safety Information:

Today’s CME session at <a href="https://twitter.com/hashtag/HRS2025?src=hashtag_click&quot; target="_blank">#HRS2025</a> was a valuable opportunity for attendees to dive into the latest evidence and treatment options for patients with both Advanced Afib and heart failure. With a dynamic session and engaging panel discussion, meaningful conversations and insights were

Today’s CME session at <a href='https://www.linkedin.com/feed/hashtag/?keywords=HRS2025&highlightedUpda…; target='_blank'>#HRS2025</a> was a valuable opportunity for attendees to dive into the latest evidence and treatment options for patients with both Advanced Afib and heart failure. With a dynamic session and engaging panel discussion, meaningful conversations and insights were shared.

Designed to reduce the risks associated with standard epicardial access techniques, the EPi-Ease™ Device is providing electrophysiologists another option for accessing the pericardium.​
Discover how by visiting us at <a href='https://www.linkedin.com/feed/hashtag/?keywords=HRS2025&highlightedUpda…; target='_blank'>#HRS2025</a> at booth 915. ​

Important Safety Information: <a href="https://okt.to/SHT5OA&quot; target="_blank">https://okt.to/SHT5OA</a&gt; ​

<a href='https://www.linkedin.com/feed/hashtag/?keywords=EPeeps&highlightedUpdat…; target='_blank'>#EPeeps</a>​

Visit us at booth 915 to connect with our team of experts at <a href="https://twitter.com/hashtag/HRS2025?src=hashtag_click&quot; target="_blank">#HRS2025</a> to explore strategies for long-term Afib burden reduction in LSPAF patients with Hybrid AF™ Therapy. Learn about the benefits of LAA exclusion and try our simulation model for hands-on experience.

Welcome to <a href='https://www.linkedin.com/feed/hashtag/?keywords=HRS2025&highlightedUpda…; target='_blank'>#HRS2025</a>! Visit us at booth 915 to connect with our team of experts and explore strategies for long-term Afib burden reduction in Advanced Afib patients with Hybrid AF™ Therapy. Learn about the benefits of LAA exclusion — a Class IA recommendation by major societies — and try our simulation model for a hands-on experience.

This week, we met with APPs, Nurses, and HCPs to discuss cardiac ablation techniques, patient selection, and developing a heart team approach to Afib treatment. Thank you to the those who joined us!

Couldn't attend? Register for the next session at: <a href="https://t.co/cHEJKjZqrw&quot; target="_blank">https://t.co/cHEJKjZqrw</a&gt;

This week, we met with APPs, Nurses, and HCPs to discuss cardiac ablation techniques, patient selection, and developing a heart team approach to Afib treatment. Thank you to the those who joined us! ​

Couldn't attend? Register for the next session at: <a href="https://okt.to/cIVnWJ&quot; target="_blank">https://okt.to/cIVnWJ</a&gt;